γ-tocotrienol-induced apoptosis in human gastric cancer SGC-7901 cells is associated with a suppression in mitogen-activated protein kinase signalling

British Journal of Nutrition

Volumn 99, Issue 6, 2008, Pages 1247-1254

  Sun, Wenguang ^a   Wang, Qi ^a   Chen, Bingqing ^a   Liu, Jiaren ^a,b   Liu, Huikun ^a   Xu, Weili ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

tocotrienol; Apoptosis; c Myc; Caspase 3; Extracellular signal regulated kinase 1 2; Poly (ADP ribose) polymerase; SGC 7901 cells

Indexed keywords

CASPASE 3; GAMMA TOCOTRIENOL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MYC PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; RAF PROTEIN; ALPHA TOCOPHEROL; ANTIOXIDANT; BAX PROTEIN, HUMAN; CHROMAN DERIVATIVE; DRUG DERIVATIVE; PLASTOCHROMANOL 8;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PROTEIN FAMILY; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; UPREGULATION; ADENOCARCINOMA; ANALYSIS OF VARIANCE; DNA FRAGMENTATION; DRUG EFFECT; METABOLISM; METHODOLOGY; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; ANTIOXIDANTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; CHROMANS; DNA FRAGMENTATION; DOWN-REGULATION; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENE PROTEINS C-RAF; STOMACH NEOPLASMS; VITAMIN E;

EID: 45549083517     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507879128     Document Type: Article

References (49)

1. International Agency for Research on Cancer (2004) Globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide, version 2.0. IARC CancerBase no. 5 [J Ferlay, F Bray, P Pisani and DM Parkin, editors). Lyon, France: IARC Press.
2. Yang L, Parkin DM, Ferlay J, Li L & Chen Y (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14, 243-250.
3. Sporn MB & Suh N (2002) Chemoprevention: An essential approach to controlling cancer. Nat Rev Cancer 2, 537-543.
4. Shukla S & Gupta S (2005) Dietary agents in the chemoprevention of prostate cancer. Nutr Cancer 53, 18-32.
5. Packer L & Landvik S (1989) Vitamin E: Introduction to biochemistry and health benefits. Ann N Y Acad Sci 570, 1-6.
6. Weber C, Podda M, Rallis M, Thiele JJ, Traber MG & Packer L (1997) Efficacy of topically applied tocopherols and tocotrienols in protection of murine skin from oxidative damage induced: By UV-irradiation. Free Radic Biol Med 22, 761-769.
7. He L, Mo H, Hadisusilo, S, Qureshi AA & Elson CE (1997) Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr 117, 668-674.
8. Nesaretnam K, Guthrie N, Chambers AF & Carroll KK (1995) Effect of tocotrienols on the-growth of a human breast cancer cell line in culture. Lipids 30, 1139-1143.
9. Qureshi AA, Sami SA, Salser WA & Khan FA (2002) Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 161 199-207.
10. Khanna S, Roy S, kyu H, Bahadduri P, Swaan PW, Ratan RR & Sen CK (2003) Molecular basis of vitamin E action: Tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem 278, 43508-43515.
11. Nesaretnam. K, Ambra R, Selvaduray KR, Radhakrishnarr A, Canali R & Virgili F (2004) Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells. Ann N Y Acad Sci 1031 143-157.
12. Noguchi N, Hanyu R, Nonaka A, Okimoto Y & Kodama T (2003) Inhibition of TBP-1 cell adhesion to endothelial cells by α-tocopherol and α-tocotrienol is dependent on intracellular concentration of the antioxidants. Free Radic Biol Med 34, 1614-1620.
13. Naito Y, Shimozawa M, Kuroda M, et al. (2005) Tocotrienols reduce 25-hydroxycholesterol-induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis 180, 19-25.
14. McIntyre BS, Briski KP, Gapor A & Sylvester PW (2000) Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med 224, 292-301.
15. Gysin R, Azzi A & Visarius T (2002) γ-Tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cycling. FASEB J 16, 1952-1954.
16. Shah S, Gapor A & Sylvester PW (2003) Role of caspase-8 activation in mediating vitamin E-induced apoptosis in murine mammary cancer cells. Nutr Cancer 145, 236-246.
17. Shun MC, Yu W, Gapor A, Parsons R, Atkinson J, Sanders BG & Kline K (2004) Pro-apoptotic mechanisms of action of a novel vitamin E analog (α-TEA) and a naturally occurring form of vitamin E. (δ-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr Cancer 48, 95-105.
18. Shah SJ & Sylvester PW (2005) γ-Tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor κB activity. Exp Biol Med (Maywood) 230, 235-241.
19. Agarwal MK, Agarwal ML, Athar M & Gupta S (2004) Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/Bc12 ratio and induces apoptosis independent of cell cycle association. Cell Cycle 3, 205-211.
20. Janmejai KS & Sanjay G (2006) Tocotrienol-rich fraction of palm oil induces cell cycle arrest and Apoptosis selectively in, human prostate cancer cells. Biochem Biophys Res Comm 346, 447-453.
21. Sakai M, Okabe M, Tachibana H & Yamada K (2006) Apoptosis induction by -tocotrienol in human hepatoma Hep3B cells. J Nutr Biochem 17 672-676.
22. Salvesen GS & Dixit VM (1997) Caspases: Intracellular signaling by proteolysis. Cell 91, 443-446.
23. Seger R & Krebs EG (1995) The MAPK signaling cascade. FASEB J 9 726-735.
24. Liang B, Wang S, Zhu XG, Yu YX, Cui ZR & Yu YZ (2005) Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer. World J Gastroenterol 11, 623-628.
25. Kasid U & Dritschilo A (2003) RAF antisense oligonucleotide as a tumor radiosensitizer. Oncogene 22, 5876-5884.
26. Marampon F, Ciccarelli C & Zani BM (2006) Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors. Mol Cancer 5, 31-48.
27. Block G, Patterson B & Subar A (1992) Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr Cancer 18, 1-29.
28. Shao ZM, Wu J, Shen ZZ & Barsky SH (1998) Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 58, 4851-4857.
29. Zhou JR, Mukherjee P, Gugger ET, Tanaka T, Blackburn GL & Clinton SK (1998) Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res 58, 5231-5238.
30. Yap SP, Yuen KH & Wong JW (2001) Pharmacokinetics and bioavailability of α-, γ- and δ-tocotrienols under different food status. J Pharm Pharmacol 53, 67-71.
31. Sylvester PW, Shah SJ & Samant GV (2005) Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of g-tocotrienol in neoplastic mammary epithelial cells. J Plant Physiol 162, 803-810.
32. Tsujimoto Y & Shimizu S (2000) Bcl-2 family: Life-or-death switch. FEBS Lett 466, 6-10.
33. Shimizu S, Narita M & Tsujimoto Y (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483-487.
34. Sylvester PW, Nachnani A, Shah S & Briski KP (2002) Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells. Asia Pac J Clin Nutr 11 Suppl. 7, S452-S459.
35. Wada T & Penninger JM (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23, 2838-2849.
36. Gysin S, Lee SH, Dean NM & McMahon M (2005) Pharmacologic inhibition of RAF-MEK-ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1. Cancer Res 65, 4870-4880.
37. Klein PJ, Schmidt CM, Wiesenauer CA, et al. (2006) The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer. Neoplasia 8, 1-8.
38. Chen BQ, Xue YB, Liu JR, Yang YM, Zheng YM, Wang XL & Liu RH (2003) Inhibition of conjugated linoleic acid on mouse forestomach neoplasia induced by benzo(a)pyrene and chemopreventive mechanisms. World J Gastroenterol 9, 44-49.
39. Liu JR, Yang BF, Chen BQ, Yang YM, Dong HW & Song YQ (2004) Inhibition of β-ionone on SGC-7901 cell proliferation and upregulation of metalloproteinases-1 and -2 expression. World J Gastroenterol 10, 167-171.
40. Liu JR, Chen BQ, Yang BF, Dong HW, Sun CH, Wang Q, Guo S & Song YQ (2004) Apoptosis of human gastric adenocarcinoma cells induced by β-ionone. World J Gastroenterol 10, 348-351.
41. Bocca C, Bozzo F, Gabriel L & Miglietta A (2007) Conjugated linoleic acid inhibits Caco-2 cell growth via ERK-MAPK signaling pathway. J Nutr Biochem 18, 332-340.
42. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
43. Chang L & Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37-40.
44. Johnson GL & Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912.
45. Sarkar D, Su ZZ, Lebedeva S IV, auane M, Gopalkrishnan RV, Valerie K, Dent P & Fisher PB (2002) mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci U S A 99, 10054-10059.
46. Porras A, Zuluaga S, Black E, Valladares A, Alvarez AM, Ambrosino C, Benito M & Nebreda AR (2004) p38 α Mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell 15, 922-933.
47. Park JM, Greten FR, Li ZW & Karin M (2002) Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297, 2048-2051.
48. Juretic N, Santibanez JF, Hurtado C & Martinez J (2001) ERK 1,2 and p38 pathways are involved in the proliferative stimuli mediated by urokinase in osteoblastic SaOS-2 cell line. J Cell Biochem 83, 92-98.
49. Yosimichi G, Nakanishi T, Nishida T, Hattori T, TakanoYamamoto T & Takigawa M (2001) CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem 268, 6058-6065.